A new genetic clue to the timing of Alzheimer’s
A genome-wide study of families with early-onset Alzheimer’s disease has identified the RNA-binding protein gene RBFOX1 as a significant factor influencing the age at which symptoms begin. The research, which combined linkage analysis in families with validation across nine independent cohorts, found that higher expression of RBFOX1 in blood was associated with an earlier disease onset. This nominates RBFOX1 as a potential therapeutic target for delaying dementia.
Why it might matter to you:
This work directly addresses the search for genetic modifiers of neurodegenerative disease progression, a core component of biomarker discovery. Identifying a gene like RBFOX1 that influences age of onset provides a concrete molecular pathway that could be integrated into multi-modal prognostic models. For your focus on clinically actionable assays, such a genetic factor could help stratify patient risk and inform the development of targeted interventions aimed at altering the disease timeline.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
